Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management
Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management
大小是否重要？这两只小市值大麻股票是现金流和信贷管理方面的专家。
C21 Investments (OTC:CXXI) and Vext Science (OTC:VEXT) have demonstrated notable financial performance, particularly in cash flow and credit stability. This is significant given the challenges faced by many larger cannabis companies.
C21投资（场外交易：CXXI）和Vext Science（场外交易：VEXT）表现突出，尤其是在现金流和信用稳定方面。这一点在许多更大的大麻股公司面临挑战的情况下显得尤为重要。
Despite market caps of $29.98 million for Vext and $33.33 million for C21, they outperform larger peers like Tilray (NASDAQ:TLRY) with a market cap of $1.53 billion, Curaleaf (OTC:CURLF) with a market cap of $3.10 billion, and Trulieve (OTC:TCNNF) with a market cap of $1.69 billion.
尽管Vext的市值为2998万美元，而C21的市值为3333万美元，但它们的表现优于市值为15.3亿美元的Tilray（纳斯达克：TLRY）、市值为31亿美元的Curaleaf（场外交易：CURLF）和市值为16.9亿美元的Trulieve（场外交易：TCNNF）等较大的同行。
Comparative Analysis With Major Cannabis Stocks
与主要大麻股票的比较分析
The leveraged free Cash Flow Margin (LFCFM) indicates how efficiently a company converts its revenue into cash after covering...
杠杆自由现金流利润率（LFCFM）表示...
登录免费看全文
登录/注册